| Product |
CAS |
Molecular formula |
More |
| (7Z,10z,13z,16z)-n-(2-hydroxyethyl)-7,10,13,16-docosatetraenamide |
150314-35-5 |
C24H41NO2 |
More |
| (8Beta,11alpha,13e,15s)-11,15-dihydroxy-9-oxo-prost-13-en-1-oic acid |
21003-46-3 |
C20H34O5 |
More |
| (5S,6z,8e,10e,14z)-5-hydroxy-12-oxoicosa-6,8,10,14-tetraenoic acid |
136696-10-1 |
C20H30O4 |
More |
| (5Z,8z,10e,12s,14z)-12-hydroxy-5,8,10,14-eicosatetraenoic-5,6,8,9,11,1 |
84807-90-9 |
C20H24D8O3 |
More |
| Delta-8-tetrahydrocannabinol |
5957-75-5 |
C21H30O2 |
More |
| Beta-estradiol 17-(beta-d-glucuronide) sodium salt |
15087-02-2 |
C24H31NaO8 |
More |
| 3-Fluoroephedrone hydrochloride |
1346600-40-5 |
C10H13ClFNO |
More |
| N-[4-(4-isopropoxybenzyl)phenyl]-4,5-dihydro-1h-imidazol-2-amine |
221529-58-4 |
C19H23N3O |
More |
| (4Z,7z,10z,13e,15e,17r,19z)-17-hydroxy-4,7,10,13,15,19-docosahexaenoic |
155976-53-7 |
C22H32O3 |
More |
| (5Z,11alpha,13e,15r)-11,15-dihydroxy-9-oxo-prosta-5,13-dien-1-oic acid |
38873-82-4 |
C20H32O5 |
More |
| (5Z,9alpha,11alpha,13e,15s)-n-ethyl-9,11,15-trihydroxy-prosta-5,13-die |
54130-36-8 |
C22H39NO4 |
More |
| (5Z,13e,15r)-15-hydroxy-16,16-dimethyl-9-oxo-prosta-5,13-dien-1-oic ac |
53658-98-3 |
C22H36O4 |
More |
| Jwh-122 5-hydroxypentyl |
1379604-68-8 |
C25H25NO2 |
More |
| (5Z,11beta,13e,15s)-11,15-dihydroxy-9-oxo-prosta-5,13-dien-1-oicacid |
38310-90-6 |
C20H32O5 |
More |
| (5Z,11alpha,13e,15s)-11,15-dihydroxy-15-methyl-9-oxo-prosta-5,13-dien- |
35700-27-7 |
C21H34O5 |
More |
| (5Z)-7-{(1r,2r,3r)-3-hydroxy-2-[(3s)-3-hydroxy-4-phenyl-1-buten-1-yl]- |
38315-44-5 |
C22H28O5 |
More |
| (5Z,11z,14z)-8,9-dihydroxy-5,11,14-icosatrienoic acid |
192461-96-4 |
C20H34O4 |
More |
| [(2E,6e)-1-hydroxy-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl]phosphonic |
148796-53-6 |
C15H27O4P |
More |
| 1,11Alpha,15s-trihydroxy-prost-13e-en-9-one |
21562-57-2 |
C20H36O4 |
More |
| (5Z,13e,15s,17z)-15-hydroxy-9-oxo-prosta-5,8(12),13,17-tetraen-1-oicac |
36614-32-1 |
C20H28O4 |
More |
|
